Uremia Clinical Manifestations and Pathophysiology
Pathophysiological Mechanisms
- The accumulation of globotriaosylceramida in the vascular endothelium leads to ischemia and infarction, particularly in the kidney, heart, and brain 1
Clinical Manifestations
Gastrointestinal Symptoms
- Nauseas, vomiting, and anorexia are frequent manifestations that significantly affect dietary intake 2
- Uremia affects gastric emptying, compromising food tolerance 2
- Diarrhea, anorexia, and gastrointestinal symptoms appear early in the course of the disease 3
Neurological Manifestations
- Neurological symptoms include confusion, lethargy, dizziness, hypotonia, headache, tremors, ataxia, dysarthria, seizures, hemiplegia, and coma 4
Cardiovascular and Respiratory Manifestations
- Serositis (pleuritis, pericarditis) is characteristic of acute uremia 5
- Edema, volume overload, congestive heart failure, and cardiac arrhythmias are common 3
Hematological Manifestations
- Platelet dysfunction predisposes to bleeding 5
Metabolic and Endocrine Manifestations
- Insulin resistance and increased catabolism occur in uremic patients 5
- Protein-energy wasting is a common complication 5
- Amenorrhea occurs in women with uremia 5
- Reduced core body temperature is observed in uremic patients 5
Other Manifestations
Specific Complications
Dialysis Disequilibrium Syndrome
- Children with hemolytic-uremic syndrome develop seizures, hemiparesis, aphasia, and visual field defects 6
- Coma at presentation and elevated protein in cerebrospinal fluid predict poor prognosis in hemolytic-uremic syndrome 6
Indications for Renal Replacement Therapy
- Consider initiating dialysis when the weekly renal Kt/Vurea falls below 2.0, especially if uremic symptoms persist 2
- The decision to initiate dialysis should be based on the assessment of signs and symptoms associated with uremia, not just on the level of glomerular filtration 5
- Providers should be diligent in seeking reversible causes of symptoms before initiating dialysis, especially in the elderly and patients with polypharmacy 5